ALK HDM Tablet
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ALK HDM Tablet, covering 2010-08-17 to 2017-12-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma [Phase 3]